Previous close | 91.49 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 5,967 |
Market cap | 151.746M |
Beta (5Y monthly) | 0.32 |
PE ratio (TTM) | 3.88 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BioMarin's (BMRN) earnings beat estimates in the first quarter of 2024, while revenues slightly miss the mark. The company maintains revenue guidance for 2024.
Q1 2024 Biomarin Pharmaceutical Inc Earnings Call
Explore key financial achievements and strategic directions from Biomarin's latest earnings call.